Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Alvarez-Larrán

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
How to Treat Essential Thrombocythemia and Polycythemia VeraCarlos Besses, Alberto Alvarez-Larrán
Current Hematologic Malignancy Reports|August 15, 2014
Antiplatelet therapy in the management of myeloproliferative neoplasmsAlberto Alvarez-Larrán, Carlos Besses
Medicina Clinica|March 16, 2013
[Treatment of essential thrombocythemia]Alberto Alvarez-Larrán, Francisco Cervantes, Carlos Besses
British Journal of Haematology|April 8, 2024
Essential thrombocythaemia: A contemporary approach with new drugs on the horizonFrancisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Alberto Alvarez-Larrán
British Journal of Haematology|August 16, 2002
Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patientsFrancisco Cervantes, Alberto Alvarez-Larrán, Carme Talarn, et al.
British Journal of Haematology|December 21, 2002
Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophilsAlberto Alvarez-Larrán, Jordi Petriz, Antonio Martínez, et al.
British Journal of Haematology|June 15, 2005
Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patientsFrancisco Cervantes, Alberto Alvarez-Larrán, Abel Domingo, et al.
Leukemia Research|October 18, 2011
Influence of JAK2 46/1 haplotype in the natural evolution of JAK2V617F allele burden in patients with myeloproliferative neoplasmsAlberto Alvarez-Larrán, Anna Angona, Luz Martínez-Avilés, et al.
Haematologica|February 8, 2006
Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational statusEduardo Arellano-Rodrigo, Alberto Alvarez-Larrán, Juan Carlos Reverter, et al.
British Journal of Haematology|November 4, 2004
Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literatureFrancisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
How to Treat Essential Thrombocythemia and Polycythemia VeraCarlos Besses, Alberto Alvarez-Larrán
Current Hematologic Malignancy Reports|August 15, 2014
Antiplatelet therapy in the management of myeloproliferative neoplasmsAlberto Alvarez-Larrán, Carlos Besses
Medicina Clinica|March 16, 2013
[Treatment of essential thrombocythemia]Alberto Alvarez-Larrán, Francisco Cervantes, Carlos Besses
British Journal of Haematology|April 8, 2024
Essential thrombocythaemia: A contemporary approach with new drugs on the horizonFrancisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Alberto Alvarez-Larrán
British Journal of Haematology|August 16, 2002
Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patientsFrancisco Cervantes, Alberto Alvarez-Larrán, Carme Talarn, et al.
British Journal of Haematology|December 21, 2002
Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophilsAlberto Alvarez-Larrán, Jordi Petriz, Antonio Martínez, et al.
British Journal of Haematology|June 15, 2005
Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patientsFrancisco Cervantes, Alberto Alvarez-Larrán, Abel Domingo, et al.
Leukemia Research|October 18, 2011
Influence of JAK2 46/1 haplotype in the natural evolution of JAK2V617F allele burden in patients with myeloproliferative neoplasmsAlberto Alvarez-Larrán, Anna Angona, Luz Martínez-Avilés, et al.
Haematologica|February 8, 2006
Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational statusEduardo Arellano-Rodrigo, Alberto Alvarez-Larrán, Juan Carlos Reverter, et al.
British Journal of Haematology|November 4, 2004
Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literatureFrancisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, et al.
Pageof 9